T2 biosystems (ttoo) outpaces stock market gains: That is because the jan 21, 2022 $2.50 call had some of the highest.
In fact, when combining a zacks rank #3 or better and a positive earnings esp, stocks produced a positive surprise 70% of.
Ttoo stock forecast zacks. T2 biosystems downgraded by zacks investment research on 10/27/2021. This change was narrower than the s&p 500's daily loss of 1.08%. Investors in t2 biosystems, inc.
The analysts previously had rating of buy. Want the latest recommendations from zacks investment research? This suggests a possible upside of 377.5% from the stock's current price.
Ttoo need to pay close attention to the stock based on moves in the options market lately. T2 biosystems stock has undergone multiple analysts rating changes in the recent past. The move came on solid volume too with.
Ttoo | complete t2 biosystems inc. Ttoo currently has a zacks rank of #3 (hold). This compares to loss of $0.09 per share a year ago.
On average, they anticipate t2 biosystems' share price to reach $2.91 in the next twelve months. This compares to loss of $0.30 per share a year ago. The zacks consensus eps estimate remained stagnant within the past month.
Today, you can download 7 best stocks for the next 30 days. The technique has proven to be very useful for finding positive surprises. This signals that analyst sentiment is improving and the stock's earnings outlook is.
T2 biosystems to participate in the canaccord genuity annual growth conference. Ttoo was a big mover last session, as the company saw its shares rise nearly 9% on the day. T2 biosystems (ttoo) came out with a quarterly loss of $0.08 per share in line with the zacks consensus estimate.
T2 biosystems, inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the united states and internationally. In a note to investors, the firm issued a new rating of hold. T2 biosystems (ttoo) reports q4 loss, tops revenue estimates.
Find the latest t2 biosystems, inc. Their forecasts range from $1.65 to $3.50. Click to get this free report t2 biosystems, inc.
Simply put, stocks with a zacks rank of 1, 2, or 3, with a positive esp were shown to positively surprise 70% of the time. By zacks equity research published on march 04,2021. (ttoo) stock discussion in yahoo finance's forum.
T2 biosystems (ttoo) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. T2 biosystems (ttoo) came out with a quarterly loss of $0.07 per share versus the zacks consensus estimate of a loss of $0.06. Share your opinion and gain insight from other stock traders and investors.
